Stride, the UK’s digital-first leader in health optimisation, has announced the acquisition of Floe, a pioneering oral health test technology. The acquisition integrates Floe’s proprietary, registered IVD saliva testing technology into the StrideOne membership and Stride’s growing range of advanced diagnostics, expanding its multi-omic platform and marking another milestone in the company’s mission to set the new standard for optimal with a comprehensive, preventative health ecosystem that connects every aspect of human biology.
Oral Health with Stride: A New Gateway to Whole-Body and Longevity Health
As global awareness grows around the link between oral health, systemic disease, and longevity, this acquisition positions Stride at the forefront of a new frontier in preventative medicine.
The mouth is a critical gateway to whole-body health, a primary pathway that connects oral inflammation to systemic conditions from diabetes to cardiovascular disease and even conditions such as Alzheimer’s. The Floe saliva test measures specific biomarkers to detect and track inflammation, providing an early, evidence-based view of both oral and systemic health.
With a simple at-home saliva test, analysed at Stride’s in-house lab, users will be able to monitor changes over time and receive tailored recommendations across lifestyle, diet, oral care, and treatment. It’s a transformative tool in the pursuit of long-term health, helping members optimise not only lifespan but healthspan on a truly holistic level.
“At Stride, we’re building the world’s first fully connected health optimisation membership. A single platform that that unites DNA, blood, microbiome, and now oral health testing into a transformative user experience,” says Andrew Steele, CEO and Co-founder of Stride. “Oral health is both an overlooked and essential indicator of overall wellbeing. With Floe’s proprietary, registered IVD technology and scientific expertise, we’re advancing towards a more complete, connected, and preventative model of healthcare that’s grounded in evidence and built for longevity.”
A Shared Vision for Medicine 3.0
William Welton, co-founder of Floe, added:
“With the acquisition of Floe’s saliva testing technology, Stride is ensuring that oral health becomes an important part of Stride’s suite of test technologies. Oral health is deeply connected to whole-body health, and by adding this simple but powerful test, members will gain even deeper insights into their wellbeing. Andrew Steele and his team bring both the expertise and ambition to build on all of Floe’s work to date. This marks another important step towards Medicine 3.0 – a future model of healthcare that is preventative, democratised, and personalised, focused on extending healthy life years rather than merely prolonging it.”
Personalised Interventions and Continuous Feedback
Based on the test results, future interventions will include:
- Optimised oral care routines — personalised guidance on brushing, flossing, and rinsing.
- Targeted product recommendations — such as higher-fluoride toothpaste, antimicrobial mouthwash, or probiotic tablets.
- Lifestyle and diet advice — covering sugar intake, smoking, alcohol, stress, and sleep habits.
- Professional follow-up — connecting users with partner dentists or hygienists if inflammation levels suggest further attention.
The Floe test acts as a feedback loop, giving users visibility into whether their current habits are keeping their mouth (and therefore their body) healthy, all while providing clear, personalised next steps.
Unlocking the Next Layer of Personalised Health
The newly integrated test will analyse thousands of oral protein and bacterial markers to generate detailed insights into:
- Oral microbiome diversity and inflammatory balance
- Gum and mucosal health
- Microbiome-linked cardiovascular and metabolic risk factors
- Personalised nutrition, lifestyle, and oral care recommendations
This addition completes the core suite of StrideOne tests — DNA, blood, microbiome, and oral — setting a new standard in holistic, multi-omic, personal health optimisation.
Stride is a digital-first health optimisation company from the UK, revolutionising how people understand and optimise their health, fitness and longevity. On a mission to make tracking internal biomarkers as common as tracking wearable data, Stride has created the world’s most comprehensive health testing membership. Stride bridges the gap between proactive wellness and reactive healthcare by analysing over 500 biomarkers across DNA, microbiome, bloods, and now oral health. Stride empowers individuals to unlock their health potential through advanced testing, personalised protocols, expert support, tailored supplementation, and continuous optimisation.
For more information, please visit getstride.com
andrew@getstride.com
Stride
